← All medicines
Tyvense 40 mg capsules, hard
Licence PA23211/005/003 · Marketed
- Licence holder
- Takeda Pharmaceuticals International AG Ireland Branch (all products →)
- Active substance
- Lisdexamfetamine dimesylate
- Dosage form
- Capsule, hard
- Route of administration
- Oral use
- ATC codes
- N06BA, N06BA12
- First authorised
- 31/07/2015
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.